Eltrombopag in Good's Syndrome.
Good's syndrome is a rare acquired immunodeficiency associated with thymoma. Eltrombopag is a thrombopoietin receptor agonist and has been shown to be a valuable supplement to the treatment of several types of refractory cytopenias. In this paper, we describe a male patient suffering from Good's syndrome with immune-mediated T-cell driven pancytopenia and absence of megakaryopoiesis. He was successfully treated with eltrombopag resulting in a multilineage clinical response.
Department of Internal Medicine, Innlandet Hospital Trust, 2629 Lillehammer, Norway.
Håvard Anton
0000-0003-0005-9689
HA
Kristiansen
Department of Pathology, Oslo University Hospital, 0424 Oslo, Norway.
Signe
0000-0002-2426-5316
S
Spetalen
Department of Hematology, Oslo University Hospital, Rikshospitalet, P.O. Box 4950, Nydalen, 0424 Oslo, Norway.
Yngvar
0000-0001-7267-1944
Y
Fløisand
Department of Hematology, Oslo University Hospital, Rikshospitalet, P.O. Box 4950, Nydalen, 0424 Oslo, Norway.
Dag
D
Heldal